Active Filters
- 2023Clear filter
Jul 14, 2023
Monitoring disease with serum tumor markers vs. imaging
Jul 5, 2023
The summer 2023 issue of the Lung-MAP Newsletter is now available!
Jun 30, 2023
Jun 14, 2023
Jun 4, 2023
Nivolumab added to AVD chemotherapy expected to become new standard for initial treatment for advanced stage disease in adolescents and adults, based on trial data to be presented at 2023 ASCO Annual Meeting plenary session
Jun 2, 2023
Results of SWOG S1929 trial show patients with small-cell lung cancer with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade